Advertisement

Topics

"CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma" Drugs and Medication Database: Page 5

11:17 EDT 19th March 2019 | BioPortfolio

Here are the most relevant "CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma" Drugs and Medications that we have found in our database.

More Information about "CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma" on BioPortfolio

We have published hundreds of CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma news stories on BioPortfolio along with dozens of CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma Clinical Trials and PubMed Articles about CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma Companies in our database. You can also find out about relevant CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma Drugs and Medications on this site too.

Showing "CDK4 Inhibition Locally Advanced Metastatic Chordoma" Drugs and Medications 101–125 of 214

Possibly Relevant

Cosmegen [recordati rare diseases, inc.]

These highlights do not include all the information needed to use COSMEGEN safely and effectively. See full prescribing information for COSMEGEN. COSMEGEN (dactinomycin for injection) for intravenous use Initial U.S. Approval: 1964

Ibrance [u.s. pharmaceuticals]

These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE (palbociclib) capsules, for oral useInitial U.S. Approval: 2015

Bicalutamide [dava pharmaceuticals, inc.]

These highlights do not include all the information needed to use Bicalutamide Tablets, USP safely and effectively. See full prescribing information for Bicalutamide Tablets, USP. Bicalutamide Tablets, USP for Oral useInitial U.S. Approval: 1995

Yervoy [e.r. squibb & sons, l.l.c.]

These highlights do not include all the information needed to use YERVOY safely and effectively. See full prescribing information for YERVOY. YERVOY (ipilimumab) injection, for intravenous useInitial U.S. Approval: 2011

Cyramza [eli lilly and company]

These highlights do not include all the information needed to use CYRAMZA safely and effectively. See full prescribing information for CYRAMZA.CYRAMZA (ramucirumab) injection, for intravenous useInitial U.S. Approval: 2014

Bicalutamide [synthon pharmaceuticals, inc.]

These highlights do not include all the information needed to use Bicalutamide Tablets, USP safely and effectively. See full prescribing information for Bicalutamide Tablets, USP. Bicalutamide Tablets, USP for Oral useInitial U.S. Approval: 1995

Alimta [eli lilly and company]

These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for ALIMTA.ALIMTA (pemetrexed for injection), for Intravenous UseInitial U.S. Approval: 2004

Vitrakvi [loxo oncology, inc.]

These highlights do not include all the information needed to use VITRAKVI safely and effectively. See full prescribing information for VITRAKVI. VITRAKVI (larotrectinib) capsules, for oral use VITRAKVI (larotrectinib) oral solutionInitial U.S. Approval:

Azedra [progenics pharmaceuticals, inc.]

These highlights do not include all the information needed to use AZEDRA safely and effectively. See full prescribing information for AZEDRA. AZEDRA (iobenguane I 131) solution for intravenous use Initial U.S. Approval: 2018

Vizimpro [u.s. pharmaceuticals]

These highlights do not include all the information needed to use VIZIMPRO safely and effectively. See full prescribing information for VIZIMPRO. VIZIMPRO (dacomitinib) tablets, for oral use Initial U.S. Approval: 2018

Vizimpro [pfizer laboratories div pfizer inc]

These highlights do not include all the information needed to use VIZIMPRO safely and effectively. See full prescribing information for VIZIMPRO. VIZIMPRO (dacomitinib) tablets, for oral use Initial U.S. Approval: 2018

Kisqali [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use KISQALI safely and effectively. See full prescribing information for KISQALI. KISQALI (ribociclib) tablets, for oral use Initial U.S. Approval: 2017

Anastrozole [nucare pharmaceuticals,inc.]

These highlights do not include all the information needed to use anastrozole tablets safely and effectively. See full prescribing information for anastrozole tablets. Initial U.S. Approval Anastrozole tablets for oral use

Faslodex [astrazeneca pharmaceuticals lp]

These highlights do not include all the information needed to use FASLODEX safely and effectively. See full prescribing information for FASLODEX.FASLODEX (fulvestrant) injection, for intramuscular useInitial U.S. Approval: 2002

Dactinomycin [mylan institutional llc]

These highlights do not include all the information needed to use DACTINOMYCIN FOR INJECTION safely and effectively. See full prescribing information for DACTINOMYCIN FOR INJECTION. DACTINOMYCIN for injection, for intravenous use Initial U.S. Approval: 19

Imfinzi [astrazeneca pharmaceuticals lp]

These highlights do not include all the information needed to use IMFINZI safely and effectively. See full prescribing information for IMFINZI. IMFINZI (durvalumab) injection, for intravenous useInitial U.S. Approval: 2017

Bicalutamide [northstar rxllc]

These highlights do not include all the information needed to use BICALUTAMIDE TABLETS safely and effectively. See full prescribing information for BICALUTAMIDE TABLETS. BICALUTAMIDE tablets, for oral use Initial U.S. Approval: 1995

Bicalutamide [cadila healthcare limited]

These highlights do not include all the information needed to use BICALUTAMIDE TABLETS safely and effectively. See full prescribing information for BICALUTAMIDE TABLETS. BICALUTAMIDE tablets, for oral useInitial U.S. Approval: 1995

Odomzo [sun pharma global fze]

These highlights do not include all the information needed to use ODOMZO safely and effectively. See full prescribing information for ODOMZO. ODOMZO (sonidegib) capsules, for oral use Initial U.S. Approval: 2015

Bicalutamide [zydus pharmaceuticals (usa) inc.]

These highlights do not include all the information needed to use BICALUTAMIDE TABLETS safely and effectively. See full prescribing information for BICALUTAMIDE TABLETS. BICALUTAMIDE tablets, for oral useInitial U.S. Approval: 1995

Bicalutamide [bryant ranch prepack]

These highlights do not include all the information needed to use BICALUTAMIDE TABLETS safely and effectively. See full prescribing information for BICALUTAMIDE TABLETS. BICALUTAMIDE tablets, for oral useInitial U.S. Approval: 1995

Bicalutamide [teva pharmaceuticals usa, inc.]

These highlights do not include all the information needed to use BICALUTAMIDE TABLETS safely and effectively. See full prescribing information for BICALUTAMIDE TABLETS. BICALUTAMIDE tablets, for oral useInitial U.S. Approval: 1995

Capecitabine [shilpa medicare limited]

These highlights do not include all the information needed to use CAPECITABINE TABLETS safely and effectively. See full prescribing information for CAPECITABINE TABLETS. CAPECITABINE tablets, Film Coated for Oral use Initial U.S. Approval: 1998

Bicalutamide [northstar rxllc]

These highlights do not include all the information needed to use BICALUTAMIDE TABLETS safely and effectively. See full prescribing information for BICALUTAMIDE TABLETS. BICALUTAMIDE tablets, for oral use Initial U.S. Approval: 1995

Dactinomycin [prasco laboratories]

Dactinomycin for injection (Actinomycin D) Rx only



Advertisement
Quick Search
Advertisement
Advertisement